Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bryce R. Anderson"'
Autor:
Won Jong Jin, Amy K. Erbe, Ciara N. Schwarz, Abigail A. Jaquish, Bryce R. Anderson, Raghava N. Sriramaneni, Justin C. Jagodinsky, Amber M. Bates, Paul A. Clark, Trang Le, Keng-Hsueh Lan, Yi Chen, KyungMann Kim, Zachary S. Morris
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In head and neck squamous cell carcinoma (HNSCC) tumors that over-expresses huEGFR, the anti-EGFR antibody, cetuximab, antagonizes tumor cell viability and sensitizes to radiation therapy. However, the immunologic interactions between cetuximab and r
Externí odkaz:
https://doaj.org/article/cb1c402282874fdc932a12949b4cd965
Autor:
Raghava N Sriramaneni, Justin C Jagodinsky, Abigail A Jaquish, Bryce R Anderson, Trang Le, Jonathan A Lubin, Ishan Chakravarty, Ian S Arthur, Clinton M Heinze, Kelsey A Klar, John S Kuo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immune checkpoint inhibition (ICI) alone is not efficacious for a large number of patients with melanoma brain metastases. We previously established an in situ vaccination (ISV) regimen combining radiation and immunocytokine to enhance res
Externí odkaz:
https://doaj.org/article/5403053984ba479cad7610cc87ac2b46
Autor:
Paul A. Clark, Joseph Grudzinski, Ian S. Arthur, Zachary S. Morris, Trang T. Le, Jamey P. Weichert, Won Jong Jin, Bryce R. Anderson, Bryan Bednarz, Eduardo Aluicio-Sarduy, Jonathan W. Engle, Raghava N. Sriramaneni, Todd E. Barnhart, Ian Marsh, Amber M. Bates, Ishan Chakravarty, Reinier Hernandez, Justin C. Jagodinsky, KyungMann Kim, Justin J. Jeffery
Publikováno v:
Radiat Res
Brain metastases develop in over 60% of advanced melanoma patients and negatively impact quality of life and prognosis. In a murine melanoma model, we previously showed that an in situ vaccination (ISV) regimen, combining radiation treatment and intr
Autor:
Zachary S. Morris, Amber M. Bates, Justin C. Jagodinsky, Won Jong Jin, Bryce R. Anderson, Ciara N. Schwarz, Abigail A Jaquish, Raghava N. Sriramaneni, Yi Chen, Keng-Hsueh Lan, Trang T. Le, KyungMann Kim, Amy K. Erbe, Paul A. Clark
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
In head and neck squamous cell carcinoma (HNSCC) tumors that over-expresses huEGFR, the anti-EGFR antibody, cetuximab, antagonizes tumor cell viability and sensitizes to radiation therapy. However, the immunologic interactions between cetuximab and r
Autor:
Zachary S. Morris, Paul A. Clark, Ian S. Arthur, Won Jong Jin, Kelsey A Klar, Jonathan A. Lubin, Jasdeep S. Kler, Amber M. Bates, John S. Kuo, Ishan Chakravarty, Bryce R. Anderson, Raghava N. Sriramaneni, Emily I. Guy, Justin C. Jagodinsky, Abigail A Jaquish, Trang T. Le, Clinton M. Heinze, Peter M. Carlson, Kyung Mann Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundImmune checkpoint inhibition (ICI) alone is not efficacious for a large number of patients with melanoma brain metastases. We previously established an in situ vaccination (ISV) regimen combining radiation and immunocytokine to enhance resp
Autor:
Amber M. Bates, Paul A. Clark, Zachary S. Morris, Alexander A. Pieper, Raghava N. Sriramaneni, Bryce R. Anderson, Alexander L. Rakhmilevich, Wonjong Jin, Justin C. Jagodinsky
Publikováno v:
Cancer Research. 80:4440-4440
Brain metastases develop in many patients with advanced metastatic cancers, and this challenging clinical scenario demands improved treatment approaches. We previously observed that an in situ vaccination (ISV) regimen combining local radiation (RT)
Autor:
Paul A. Clark, Abigail A Jaquish, Zachary S. Morris, Wonjong Jin, Amy K. Erbe, Justin C. Jagodinsky, Ciara N. Schwarz, Bryce R. Anderson, Raghava N. Sriramaneni
Publikováno v:
Cancer Research. 80:1881-1881
Purpose: Patients with head and neck squamous cell carcinoma (HNSCC) treated with anti-EGFR (cetuximab) mAb-based immunotherapy often acquire therapy-resistance, reducing clinical benefit. We evaluated the efficacy of a combined modality in situ vacc